Search

everythinglearnresearchcommunity

for

Search:↓

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

A man developed facial skin lesions after a stem cell transplant, which improved with specific treatments.

Frozen-thawed fibroblast sheets enhance wound healing and hair growth in mice.

Stem cells from fat improve dog wound healing better than standard treatment.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

The immune system can cause permanent skin and hair whitening by attacking pigment cells.

MicroRNAs could improve skin tissue engineering by regulating cells and changing the skin's bioactive environment.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Tissue engineering advancements are improving skin substitutes for better burn treatment.

Combining UVB irradiation and anti-CD154 antibody improves hair follicle transplant survival.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

Somatostatin helps hair follicles suppress immune responses, which might aid in treating certain hair loss conditions.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

Transplanted bone marrow cells actively move, form clusters, and grow after transplantation.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

UV light helped human hair transplants survive in mice without broad immunosuppression.

AHST shows promise for treating type 1 diabetes but needs more research before widespread use.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

A man with alopecia universalis regrew hair temporarily after a bone treatment.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Hair transplantation between identical twins can successfully treat severe, nonprogressive hair loss due to follicular aplasia.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.